poisar

Stocks · News reference

8-K filing — Anterix Inc. (ATEX)

SEC EDGARSEC EDGAR

Filed: 2026-08-06 AccNo: 0001304492-26-000041 Size: 203 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Why Is Anterix (ATEX) Down 5.5% Since Last Earnings Report?

    Anterix (ATEX) reported mixed Q1 fiscal 2027 results with 38.1% year-over-year revenue growth driven by spectrum revenues, but missed top-line consensus estimates. The company posted a narrower-than-expected non-GAAP net loss of 53 cents per share versus 55 cents consensus. Despite strong cash position of $119.92 million with no debt, shares have underperformed the S&P 500 by 5.5% since earnings. The stock holds a Zacks Rank #3 (Hold) with upward estimate revisions but poor Growth and Value scores.